Impact Biomedical (IBO) EBITDA Margin (2022 - 2026)
Impact Biomedical (IBO) reported EBITDA Margin of -1733.33% for Q3 2026, up 1933.33 percentage points from -3666.67% a year earlier and up 12200.00 percentage points from the prior quarter.
Impact Biomedical (IBO) EBITDA Margin (2022 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Impact Biomedical's EBITDA Margin came in at -9657.89%, up 81322.75 percentage points year-over-year; for FY2025, it came in at -9803.13%, up 202766.11 percentage points from FY2024.
- EBITDA Margin has a three-year change of -5221.13 percentage points (FY2022 to FY2025).
- By year, EBITDA Margin came in at -212569.23% in FY2024 (-190200.00 pp), -22369.23% in FY2023 (-17787.23 pp) and -4582.00% in FY2022.
- The Q3 2026 figure ranks as the highest quarterly EBITDA Margin since Q2 2022.
- Year over year, EBITDA Margin gained in three of the last eight quarters, with an average year-over-year change of +3480.36 percentage points.
- The high point for year-over-year EBITDA Margin in five years was Q4 2025 (a gain of 852438.10 percentage points); the low point was Q4 2024 (a drop of 836433.33 percentage points).
- Per Business Quant data, the three quarters before Q3 2026 came in at -13933.33% (Q2 2026), -28628.57% (Q1 2026) and -12628.57% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 42.49% |
| 10 | Impact Biomedical | 43.92 Mn | 47.11 Mn | 15,000.00 | -1,733.33% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -1,733.33% |
| Jun 30, 2026 | -13,933.33% |
| Mar 31, 2026 | -28,628.57% |
| Dec 31, 2025 | -12,628.57% |
| Sep 30, 2025 | -3,666.67% |
| Jun 30, 2025 | -12,357.14% |
| Mar 31, 2025 | -24,233.33% |
| Dec 31, 2024 | -865,066.67% |
| Sep 30, 2024 | -28,200.00% |
| Jun 30, 2024 | -11,566.67% |
| Mar 31, 2024 | -16,366.67% |
| Dec 31, 2023 | -28,633.33% |
| Sep 30, 2023 | -26,600.00% |
| Jun 30, 2022 | -944.00% |
Impact Biomedical EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "IBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();